5Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging [J]. Skeletal Radiol, 2007,36(12):1109-1119.
7Kosuda S, Kaji T, Yokoyama H, et al. Does bone SPECT actually have lower sensitivity for detecting vertebral metastasis than MRI? [J]. J Nucl Med, 1996, 37(6):975-978.
6Sehmidt GP, Reiser MF, Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol, 2007,36(12) : 1109-1119.
7Fogelman I, Cook G, Israel O, et al. Positron emission tomography and bone metastases. Semin Nuel Med, 2005,35(2) : 135- 142.
8Gayed I, Vu T, Johnson M, et al. Comparison of hone and 2-deoxy-2-[18F]fluoro D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Mol Imaging Biol, 2003,5(1) :26-31.
9Fujimoto R, Higashi T, Nakamoto Y, et al. Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET. Ann Nucl Med, 2006,20(6) :399-408.
10Metser U, Lerman H, Blank A, et al. Malignant involvement of the spine: assessment by ^18F FDG PET/CT. J Nucl Med, 2004, 45(2) :279-284.
1FEDERICO M, MAGIN LR, SWARTZ MH, et al. Detection of eentrum marrow involvement in patients with cancer[J]. Tumour, 2003, 75(1): 90-96.
2SCHM1DT GP, REISER MF, BAUR-MELNYK A. Whole-bodyimagingo: the musculoskeletal system: the value of MR imaging [J]. Skeletal Radiol, 2007, 36(12): 1109-1119.
3SCHM1DT GP, REISER MF, BAUR-MELNYK A. Whole-bodyimagingo the musculoskeletal system: the value of MR imaging [J]. Skeletal Radiol, 2007, 36(12): 1109-1119.
4ERTURAN S, YAMAN M, AYDIN G, et al. The role ofwhole bodybone scanning and clinical factors in detecting bonemetas- rases in patientswith non-small cell lung cancer[J]. Chest, 2005, 127(2): 449-454.
